Avermectin b1a monosaccharide

CAS : 71831-09-9

Ref. 3D-WCA83109

Informations sur le produit

• Nom: Avermectin b1a monosaccharide

Description

Avermectin B1a monosaccharide is a versatile compound that has various applications in research and chemical studies. It can be used as an electrode for electrochemical experiments or as a reactive agent in different reactions. Additionally, it has been found to inhibit the activity of mitogen-activated protein kinases, which play a crucial role in cellular signaling pathways.

Furthermore, Avermectin B1a monosaccharide has potential anticoagulant properties. Studies have shown that it can interact with dipotassium tetramine, dopamine, domperidone, and other molecules involved in blood clotting processes. This makes it a promising candidate for the development of new anticoagulant drugs.

Moreover, Avermectin B1a monosaccharide has been studied for its ability to inhibit protein kinase activity. Protein kinases are enzymes that regulate various cellular processes, including cell growth and division. By targeting these enzymes, Averm

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 728.9 g/mol
• Formule: C₄₁H₆₀O₁₁
• Degré de pureté: Min. 95%